SHENZHEN, China, August 8, 2022 /PRNewswire/ — BGI has surpassed that Asia Pacific and China Ranking of life science corporate institutions for the seventh year in a row, published in the 2022 Nature Index annual tables. With a 19 percent increase in its adjusted stock metric, BGI ranked eighth among global life science corporate institutions, an improvement from the tenth place in the previous year.
The Nature Index is an indicator of institutional research performance. Percentage – the key metric of the Nature Index – is a fraction for an article attributed to an institution that takes into account the proportion of the article’s authors from that institution.
Among the top ten life science corporate institutions worldwide are six institutions from the US such as Pfizer, three from the US Europe like Roche, with BGI being the only APAC and Chinese institution on this list.
BGI’s key research highlights for 2021 include:
Zhou, Yang, et al. “Platypus and echidna genomes reveal mammalian biology and evolution.” Messages from naturepublishing group nature, January 6, 2021.
Bi, Xupen et al. “Tracing the Genetic Footprints of Vertebrate Landing in Non-Teleoste Ray-Finned Fishes.” cell, Flight. 184, No. 5, 2021.
Wei, Tonget al. “Whole genome resequencing of 445 Lactuca accessions reveals domestication history of lettuce.” natural genetics, Vol. 53, No. 5, 2021, p. 752-760.
Yang, Chentao et al. “Evolutionary and biomedical insights from a Marmoset diploid genome assembly.” Nature, vol. 594, no. 7862, 2021, p. 227-233.
Xiang, Xi et al. “Improving CRISPR-Cas9 Grna Efficiency Prediction Through Data Integration and Deep Learning.” nature communication, Flight. 12, No. 1, 2021.
Varshney RK, Roorkiwal M, Sun S et al. “A genetic variation map for chickpeas based on the sequencing of 3,366 genomes.”Nature 599, 622-627 (2021).
BGI was “born global” when they were founded September 9, 1999 by a group of young scientists to participate and fulfill the global Human Genome Project of China Mission to sequence approximately 1% of the entire human genome. Since then, research at the BGI has often involved collaborations with various global institutions.
BGI is currently leading international research projects such as the Ten Thousand Plant Genome Project and the Ten Thousand Bird Genome Project to sequence the genomes of 10,000 plants and birds respectively. BGI is also active in clinical research collaboration involving genetic testing with high specificity and sensitivity.
About the Nature Index
The Nature Index was first published in Nov 2005. Count and Share metrics, used to order entries in the Nature Index, are based on an institution’s publications in 82 science journals, selected for reputation by an independent panel of leading scientists in their fields. The Nature Index provides absolute counts and fractional share counts of published articles at the institutional and national levels, and as such is an indicator of high-quality research and collaboration around the world.
About BGI Genomics
BGI Genomics headquartered in Shenzhen China, is the world’s leading provider of genomic sequencing and proteomics services. We enable scientists and researchers to reach their full potential by providing them with fully integrated genome sequencing, proteomic services and high quality solutions for a range of applications. Our services cover more than 100 countries and regions and include more than 2,300 medical institutions.
View original content to download multimedia: https://www.prnewswire.com/news-releases/bgi-ranks-no-1-among-apac-and-china-life-science-corporations-for-seven -consecutive-years-2022-nature-index-annual-tables-disclosed-301600701.html
SOURCE BGI Genomics